Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis demonstrates that mobile health apps significantly improve quality of life during cancer chemotherapy, indicating strong utility in oncology care.
Background Cancer chemotherapy is associated with significant deterioration in quality of life (QoL) and challenges in treatment adherence. Mobile health (mHealth) applications represent a promising digital intervention for supporting patients throughout the chemotherapy trajectory. Objective To systematically evaluate the effectiveness of patient-facing mHealth applications in improving QoL and treatment adherence among adult cancer patients actively undergoing chemotherapy, and to quantify the pooled effect size through meta-analysis. Methods A systematic search was conducted across seven databases from January 2014 to June 2026. Randomised controlled trials (RCTs), quasi-experimental, and cohort studies enrolling adults receiving chemotherapy with a patient-facing mHealth intervention reporting QoL or adherence outcomes were included. Results Twenty-two studies (n = 3505 participants; 14 RCTs, 5 quasi-experimental, 1 cluster-RCT, 1 protocol) across 11 countries were included. Of 19 studies reporting QoL outcomes, 17 (89%) demonstrated statistically significant improvements in favour of the mHealth intervention. The pooled random-effects estimate demonstrated a large, statistically significant effect on QoL (Hedges’ g = 0.981, 95% CI: 0.336 to 1.626, P = 0.003; k = 9, n = 939). Medication adherence was significantly improved in five studies. Overall certainty of evidence was rated as moderate (GRADE). Conclusions Patient-facing mHealth applications produce large, significant improvements in QoL during cancer chemotherapy. Interventions grounded in nursing theory and incorporating real-time clinician feedback yield the largest effects. Integration of mHealth into oncology pharmacy practice models is warranted. Standardised outcome reporting and head-to-head comparative trials are needed.
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: